Advanced Biomed (ADVB) Profit After Tax (2023 - 2026)

Advanced Biomed has reported Profit After Tax for 4 years, with the latest figure at -$488942.0 in Q1 2026.

• Quarterly Profit After Tax rose 59.17% year-over-year to -$488942.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (up 257.27% YoY) and the FY2025 annual result came in at -$3.3 million, down 17.13% from the prior year.
• Profit After Tax eased to -$488942.0 in Q1 2026 per ADVB's latest filing, from $6.9 million in the prior quarter.
• Over five years, Profit After Tax peaked at $6.9 million in Q4 2025 and troughed at -$1.5 million in Q2 2025.
• A 4-year average of $33031.5 and a median of -$593898.5 in 2023 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 1283.43% in 2025, down 84.94% in 2025.
• Over 4 years, Profit After Tax stood at -$608303.0 in 2023, then advanced by 4.74% to -$579494.0 in 2024, then soared by 1283.43% to $6.9 million in 2025, then slumped by 107.13% to -$488942.0 in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$488942.0, $6.9 million, and -$386901.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.